Latest Retinitis pigmentosa Stories
A new study reports that transplanted pigment-containing visual cells derived from human embryonic stem cells (hESCs) successfully preserved structure and function of the specialized light-sensitive lining of the eye (known as the retina) in an animal model of retinal degeneration.
A South Jersey man says his eyesight is returning, weeks after doctors at Wills Eye Institute in Philadelphia implanted electrodes behind his left eye. Michael Adler, 49, began losing his sight as a child, The Philadelphia Inquirer reported Tuesday.
A team of scientists from the University of Wisconsin-Madison School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells â€” suggesting a future in which damaged retinas could be repaired by cells grown from the patient's own skin.
US researchers said on Wednesday that a year after receiving gene therapy for a condition that causes total blindness by age 30, three people continue to see better and one has improved enough to read the digital numbers on a clock.
People with poor eyesight caused by diseases often can be helped with various vision aids, a U.S. newsletter says. Experts at the Mayo Clinic Women's HealthSource say such low vision isn't just the normal trouble people have reading small print as they get older.
Scientists use a new technique consisting of the induction of neuronal degeneration for intense light exposure in the mouseâ€™s retina, an experimental model of retinitis pigmentosa
Research lead by Dr. Nicolas Bazan, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans
Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for human clinical trials.
- A poem in which the author retracts something said in an earlier poem.